In this work, AuNPs and cetuximab-AuNPs with different sizes were synthesized and it was desired to study their cytotoxicity on BRAF-mutant HT-29 CRC cells (RAS wild-type) to advance the understanding of treatment response for cancers with BRAF mutation. This evidence concerns the gene BRAF and cancer.